ABL Bio Logo

ABL Bio

🇰🇷
298380
KR7298380007

Based in South Korea, ABL Bio is a leading biotechnology company specializing in the development of innovative bispecific antibody therapies. Through state-of-the-art platforms, ABL Bio focuses on creating transformative solutions for oncology and neurodegenerative diseases.

Next Quarterly Earnings

Tuesday, November 17, 2026
CW 47
Pre-Market
In 82 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on October 20, 2026

Stock Price

Frequently asked questions

When will ABL Bio report its next quarterly earnings?

ABL Bio is scheduled to report its next quarterly earnings on 11/17/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did ABL Bio last report quarterly earnings?

ABL Bio last reported quarterly earnings on 3/12/2026 (Q4 2025). Earnings per share (EPS) came in at -734.00 KRW.

How do I add the ABL Bio earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:
Actual:
Q4 2025
Missed
Estimate:-₩253.40
Actual:-₩734.00
Difference:-₩480.60

Company Information

Name
ABL Bio
Ticker Symbol
298380
ISIN
KR7298380007
Country
🇰🇷
Korea, Republic of
Sector
More Financial Information